Medicines for Malaria Venture (MMV)
@mmv.org
250 followers 160 following 160 posts
A leading global health partnership working to reduce the burden of malaria. We discover, develop and deliver new antimalarial medicines.
Posts Media Videos Starter Packs
mmv.org
Yesterday, MMV and Africa CDC invited partners to a workshop in Accra to exchange insights and brainstorm ways to strengthen regional supply chains for #malaria medicines in Africa.

Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
mmv.org
Ghana launches Coartem® Baby – the first #malaria medicine for newborns & infants – as momentum continues to build across Africa.

🌍 8 more countries are set to approve soon. bit.ly/4mPN8da
Coartem® Baby launches in Ghana | Medicines for Malaria Venture
Coartem Baby is the first malaria medicine to be approved for young infants
bit.ly
mmv.org
Africa’s first-ever Phase 3 adaptive platform trial of #malaria treatments in early pregnancy has enrolled its first patient in Mali – a landmark moment for the SAFIRE consortium conducting the trial. 

Press release 👉 bit.ly/4hbmURr

#SAFIRE4MalariaInPregnancy
First patient enrolled in historic Phase 3 clinical trial to treat malaria in first-trimester pregnancy | Medicines for Malaria Venture
A major milestone in Africa’s first-ever study assessing malaria treatments in early pregnancy.
bit.ly
mmv.org
Meet the organization built on the values it takes to achieve a malaria-free future – collaboration, innovation, openness and equity.

Together, we can end #malaria – will you join us?
mmv.org
At a moment when global health must accelerate progress & deliver innovations to strengthen security, Gates Foundation is committing $912M to The Global Fund to fight #HIV, #TB & #malaria.
Read about this pledge & why “we can’t stop at almost”
👉 bit.ly/4nkCfB4
With Millions of Children’s Lives on the Line, Bill Gates Says Humanity Is at a Crossroads
At 2025 Goalkeepers event, Gates lays out roadmap for saving millions more children’s lives by 2045 if governments stretch every dollar and scale a pipeline of affordable, lifesaving innovations
bit.ly
mmv.org
SMC, vector control & vaccines are a powerful trio against #malaria.

A new PLOS Health review shows SMC cuts illness & deaths in kids <5 in Africa’s Sahel — but scaling it means tackling logistics, adherence & access in remote areas.

👉bit.ly/46wcCGB
mmv.org
Today, MMV and @deepmirror.bsky.social convened 40+ scientists in Geneva to co-create the dd4gh platform. Together, we’re using AI/ML to accelerate #malaria drug discovery while building a more inclusive global research community. Next stop: Accra.

👉 Read more: bit.ly/46xigrJ
mmv.org
MMV & partners, with support from Global Health Innovative Technology (GHIT) Fund, have launched a Phase 3 trial of a novel triple therapy (TACT) – the first for uncomplicated #malaria – to help tackle drug resistance & protect the efficacy of existing medicines.

👉 bit.ly/4guQL6L
Phase 3 clinical trial started for the first malaria treatment combining three drugs | Medicines for Malaria Venture
A novel way to extend the lifecycle of current drugs in the face of growing resistance.
bit.ly
mmv.org
A single dose, a stronger #malaria elimination strategy.
👏Congrats to Peru for adopting single-dose tafenoquine + point-of-care G6PD testing to fight relapsing malaria – a milestone made possible through strong research partnerships 👉 bit.ly/3K9GWzj
mmv.org
Are the mosquitoes that transmit #malaria changing with fluctuating climate conditions?

A new @itmantwerp.bsky.social study shows warmer, variable conditions can “reprogram” mosquito biology, making them more resilient & altering transmission patterns 👉 bit.ly/46xVmBH
Climate change could reprogram malaria mosquitoes
First-of-its-kind simulations uncover climate impacts on Anopheles stephensi.
bit.ly
mmv.org
In @telegraphnews.bsky.social, Dr Ibrahima Socé Fall argues that tackling #malaria, #dengue & #TB is key to saving lives today and preparing for future outbreaks of pandemic potential. 👉 bit.ly/3I4hcU0
mmv.org
For the 4th year in a row, MMV is a ‘very high performer’ in the Global Health 50/50 report.

Gender equity drives better science, stronger partnerships and impact in #malaria elimination, and it’s essential to global health security.

Learn more 👉 bit.ly/4glIWAb
MMV ranked as a global health leader in workplace fairness and equity | Medicines for Malaria Venture
For the fourth consecutive year, MMV has been classified as a ‘very high performer’ by Global 50/50, an independent research initiative that works to advance action and accountability for gender equal...
bit.ly
mmv.org
📢 The Big Push Against Malaria is accelerating global progress towards eradication. On the sidelines, the SMC Alliance — including MMV — is reaffirming the crucial role of seasonal #malaria chemoprevention in protecting children during peak seasons 👉 bit.ly/4ngUhUr
mmv.org
Each addition to the #malaria prevention toolbox advances the elimination agenda. Last month, @who.int recommended spatial emanators, the 1st new vector control product in +40 years. Here's how spatial emanators can help prevent deadly mosquito bites: bit.ly/4njHRLQ
How a Malaria-Fighting Breakthrough Provides Lasting Protection
A UCSF-led study finds a new class of insecticide that can be disseminated on material the size of a sheet of paper that offers protection for up to a year against mosquitoes that spread malaria, as w...
bit.ly
mmv.org
Partial resistance to artemisinin threatens #malaria treatments (ACTs) and risks undoing decades of progress. A new @thelancetinfdis.bsky.social study shows how diversifying ACT use in endemic countries could protect efficacy & buy time for next-gen drugs. 👉 bit.ly/41yFRH1
mmv.org
This Wednesday, @path.org will host a webinar on expanding the impact of #malaria chemoprevention. Join to learn about implementation experiences & how to deliver these prevention tools more widely & equitably. Register here 👉 bit.ly/3UZRDXa
mmv.org
Africa is facing a perfect storm against #malaria, including drug resistance, critical funding gaps & climate change.

At #RC75, Ministers of Health, partners & global health leaders issued an urgent call to accelerate malaria prevention & control: bit.ly/45YEqmv
mmv.org
#TICAD9 concluded with the Yokohama Declaration, reinforcing Japan-Africa collaboration for development & stability. Civil society advocates have responded with a statement supporting stronger health security & sustainable development in Africa: bit.ly/46ouEun
mmv.org
The authorization of the first-ever #malaria treatment for newborns & young infants represents a major step towards closing a decades-long gap in paediatric malaria care. But why did it take so long to achieve this milestone? @scidevnet.bsky.social investigates: bit.ly/47Y94Px
Why the wait for effective newborn malaria treatment?
A new antimalarial drug for newborn babies highlights a longstanding gap in paediatric medicine.
bit.ly
mmv.org
The 6th PAVE LATAM meeting in Lima gathered partners to align science & policy for relapsing vivax #malaria elimination. From new treatments to cross-border collaboration, momentum is growing. MMV is proud to co-lead this effort with @path.org. Stay tuned for highlights!
Reposted by Medicines for Malaria Venture (MMV)
lshtm-malaria.bsky.social
Behind every breakthrough is a dedicated face in the lab

Meet the scientists & technicians @lshtm.bsky.social & @mrcunitgambia.bsky.social working to understand 🦟 & fight malaria, dengue, Zika, & more.

This #WorldMosquitoDay2025, let’s shine a light on their vital work.

👉 bit.ly/45qtn6F
mmv.org
With 14,000 mosquitoes for every human on the planet, we need to level the playing field in the fight against diseases they spread. PDPs like MMV & @dndi.org work across the global health community to deliver new tools & ensure access where they’re needed most. #WorldMosquitoDay
World Mosquito Day
YouTube video by Medicines for Malaria Venture (MMV)
www.youtube.com
mmv.org
🚀 Imagine a world where #malaria is a thing of the past. With next-gen medicines, innovative #vaccines & smart vector control combined, we’ll be one step closer. Join us this #WorldMosquitoDay in combating malaria, a disease spread by the world’s most dangerous animal.
mmv.org
Recent studies are exploring how genetic tools can interrupt #malaria transmission at different biological stages – from modifying mosquitoes to block parasite development, to reducing their ability to pass it on. Learn more about this research: bit.ly/4olRomL
mmv.org
💊 Resistance to life-saving #malaria medicines threatens 2 decades of progress against the disease.

In response, MMV and partners are accelerating #innovation, development and access to next-generation antimalarials with high barriers to resistance: bit.ly/3Zso5ow
Antimalarial drug resistance: MMV's response | Medicines for Malaria Venture
An overview of MMV's approach to tackling antimalarial drug resistance.
bit.ly